0000096943-17-000075.txt : 20170511 0000096943-17-000075.hdr.sgml : 20170511 20170511180151 ACCESSION NUMBER: 0000096943-17-000075 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20170505 FILED AS OF DATE: 20170511 DATE AS OF CHANGE: 20170511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TELEFLEX INC CENTRAL INDEX KEY: 0000096943 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 231147939 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 550 E SWEDESFORD RD STREET 2: SUITE 400 CITY: WAYNE STATE: PA ZIP: 19087 BUSINESS PHONE: 610-225-6800 MAIL ADDRESS: STREET 1: 550 E SWEDESFORD RD STREET 2: SUITE 400 CITY: WAYNE STATE: PA ZIP: 19087 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Deren John CENTRAL INDEX KEY: 0001706189 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-05353 FILM NUMBER: 17835694 MAIL ADDRESS: STREET 1: 550 E. SWEDESFORD ROAD STREET 2: SUITE 400 CITY: WAYNE STATE: PA ZIP: 19087 3 1 wf-form3_149454009565236.xml FORM 3 X0206 3 2017-05-05 0 0000096943 TELEFLEX INC TFX 0001706189 Deren John C/O 550 E. SWEDESFORD ROAD SUITE 400 WAYNE PA 19087 0 1 0 0 VP & Chief Accounting Officer Common Stock 3881 D Common Stock 4.203 I By 401(k) Trustee Stock Option / (Right to Buy) 79.48 2023-07-29 Common Stock 1258.0 D Stock Option / (Right to Buy) 101.12 2024-02-26 Common Stock 988.0 D Stock Option / (Right to Buy) 121.0 2025-02-25 Common Stock 1950.0 D Stock Option / (Right to Buy) 144.79 2026-03-01 Common Stock 3543.0 D Stock Option / (Right to Buy) 191.18 2027-02-28 Common Stock 3645.0 D Represents the total of (a) 2,344 shares held directly by the reporting person; (b) 572 shares underlying a restricted stock award that was granted on 2/25/2015; (c) 544 shares underlying a restricted stock award that was granted on 3/1/2016; and (d) 421 shares underlying a restricted stock award that was granted on 2/28/2017. Each restricted stock award vests in its entirety on the third anniversary of the grant date. Total number of shares is based on a plan statement dated as of May 5, 2017. This stock option, which was granted on 7/29/2013 and provided the reporting person the right to purchase up to 5,906 shares, became exercisable for one-third of the shares on each of 7/29/2014, 7/29/2015 and 7/29/2016. A portion of this stock option was previously exercised. This stock option, which was granted on 2/26/2014 and provided the reporting person the right to purchase up to 5,664 shares, became exercisable for one-third of the shares on each of 2/26/2015, 2/26/2016 and 2/26/2017. A portion of this stock option was previously exercised. This stock option, which was granted on 2/25/2015 and provided the reporting person the right to purchase up to 5,850 shares, became exercisable for one-third of the shares on each of 2/25/2016, 2/25/2017 and 2/25/2018. A portion of this stock option was previously exercised. This stock option, which was granted on 3/1/2016 and provided the reporting person the right to purchase up to 5,314 shares, became exercisable for one-third of the shares on each of 3/1/2017, 3/1/2018 and 3/1/2019. A portion of this stock option was previously exercised. Exercisable for one-third of the shares on each of 2/28/2018, 2/28/2019 and 2/28/2020. Remarks: Note: Also see attached Exhibit EX-24 Power of Attorney. Daniel V. Logue w/POA for John Deren 2017-05-11 EX-24 2 poaderen-2017.txt POWER OF ATTORNEY - DEREN POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of James J. Leyden, Daniel V. Logue, Dwayne A. Ritchie or Victoria C. Alff signing singly, the undersigned's true and lawful attorney-in-fact to: (1)execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of Teleflex Incorporated (the Company), Forms 3, 4, and 5 in accordance with Section 16(a)of the Securities Exchange Act of 1934 and the rules thereunder; (2)do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority, which actions shall include, without limitation, all actions required to obtain new or replacement EDGAR access codes required to submit Form 3, 4 and 5 filings with the SEC;and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney- in-fact's discretion. The undersigned hereby grants to each such attorney- in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact,in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 8th day of May 2017. /s/ John Deren John Deren